Senior insider sale
Chief Business Officer at PLIANT THERAPEUTICS, INC. — senior position signals high conviction
$660.0K
34.92K shares
What this filing means
HULL HANS plans to sell 34.92K shares of PLIANT THERAPEUTICS, INC. valued at approximately $660.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/3/2023ACC: 0001950047-23-002742
Officer· Chief Business Officer
Since Jun 2020
34.92K
Shares to sell
$660.0K
Approx. market value
34.92K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Exercise of Stock Options
Cash
8/3/2023
10.59KPerformance Stock Units
N/A
7/28/2022
8.83KRestricted Stock Units
N/A
5/26/2021
13.08KEmployee Stock Purchase Plan
Cash
2/26/2021
2.42KTotal acquired34.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/3/2023 | Exercise of Stock Options Cash | 10.59K | — |
7/28/2022 | Performance Stock Units N/A | 8.83K | — |
5/26/2021 | Restricted Stock Units N/A | 13.08K | — |
2/26/2021 | Employee Stock Purchase Plan Cash | 2.42K | — |
| Total | 34.92K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
34.92K
Market value
$660.0K
8/3/2023
Total
Units
34.92K
Value
$660.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/3/2023 | 34.92K | $660.0K | NASDAQ | Planned |
| Total | 34.92K | $660.0K | ||